ID   P3X63Ag8U.1
AC   CVCL_3412
AS   CVCL_4268
SY   P3-X63-Ag8-U1; P3-X63-Ag8.U1; P3-X63.Ag8.U1; P3-X63Ag8U1; P3X63-Ag8-U1; P3X63Ag8-U1; P3X63Ag8.U1; P3.x63.Ag8.U1; P3U1; P3UI; P3U-1; P3-U1
DR   CLO; CLO_0008333
DR   CLO; CLO_0008336
DR   CLDB; cl3839
DR   CLDB; cl3847
DR   CLDB; cl3848
DR   CLDB; cl3849
DR   CLDB; cl3850
DR   ATCC; CRL-1597
DR   ECACC; 85011417
DR   ECACC; 94120802
DR   ICLC; ATL96012
DR   JCRB; JCRB0708
DR   JCRB; JCRB9085
DR   NCBI_Iran; C579
DR   Wikidata; Q54937289
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse plasma cell myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 16
//